Actieve functies van Karim Dabbagh
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| MAAT PHARMA | Voorzitter | 21-06-2023 | - |
| Independent Dir/Board Member | 21-06-2023 | - |
Loopbaan van Karim Dabbagh
Eerdere bekende functies van Karim Dabbagh
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Second Genome, Inc.
 Second Genome, Inc. BiotechnologyHealth Technology Second Genome, Inc. develops microbiome-based therapeutic products. It offers phyclochip community, 16S sequencing community analysis, whole metagenomic profiling, nucleic acid isolation, inferred function and custom informatics services. The company was founded in 2009 by Corey S. Goodman, Janet A. Warrington, Todd Z. DeSantis, John Hulls and Gary Andersen and is headquartered in South San Francisco, CA. | Directeur/Bestuurslid | 11-09-2018 | 01-09-2023 |
| Algemeen Directeur | 11-09-2018 | 01-09-2023 | |
| Hoofd Techniek/Wetenschap/O&O | 01-01-2014 | 01-12-2020 | |
| President | 11-09-2018 | 01-09-2023 | |
| Modus Biomedicine, Inc. | Algemeen Directeur | 01-08-2009 | 01-12-2010 |
| Oprichter | 01-08-2009 | 01-12-2010 |
Opleiding van Karim Dabbagh
| Imperial College London | Undergraduate Degree |
| University College London | Doctorate Degree |
Statistieken
Internationaal
| Verenigd Koninkrijk | 3 |
| Verenigde Staten | 3 |
| Frankrijk | 2 |
Operationeel
| Chief Executive Officer | 2 |
| Director/Board Member | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectoraal
| Consumer Services | 3 |
| Health Technology | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| MAAT PHARMA | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Second Genome, Inc.
Second Genome, Inc. BiotechnologyHealth Technology Second Genome, Inc. develops microbiome-based therapeutic products. It offers phyclochip community, 16S sequencing community analysis, whole metagenomic profiling, nucleic acid isolation, inferred function and custom informatics services. The company was founded in 2009 by Corey S. Goodman, Janet A. Warrington, Todd Z. DeSantis, John Hulls and Gary Andersen and is headquartered in South San Francisco, CA. | Health Technology |
| Modus Biomedicine, Inc. |
- Beurs
- Insiders
- Karim Dabbagh
- Ervaring
